ATE480229T1 - Orale pharmazeutische zusammensetzung zur behandlung einer cox-2-vermittelten erkrankung - Google Patents
Orale pharmazeutische zusammensetzung zur behandlung einer cox-2-vermittelten erkrankungInfo
- Publication number
- ATE480229T1 ATE480229T1 AT06831741T AT06831741T ATE480229T1 AT E480229 T1 ATE480229 T1 AT E480229T1 AT 06831741 T AT06831741 T AT 06831741T AT 06831741 T AT06831741 T AT 06831741T AT E480229 T1 ATE480229 T1 AT E480229T1
- Authority
- AT
- Austria
- Prior art keywords
- cox
- pharmaceutical composition
- oral pharmaceutical
- treating
- mediated disease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68377605P | 2005-05-24 | 2005-05-24 | |
US68377705P | 2005-05-24 | 2005-05-24 | |
EP05300407A EP1726301A1 (de) | 2005-05-24 | 2005-05-24 | Pharmazeutische Zusammensetzung zur Behandlung COX-2 vermittelter Krankheiten |
EP05300406A EP1726300A1 (de) | 2005-05-24 | 2005-05-24 | Orale pharmazeutische Formulierung zur Vorbeugung und/oder Behandlung kardiovaskulärer und inflammatorischer Erkrankungen |
PCT/IB2006/003659 WO2007036809A2 (en) | 2005-05-24 | 2006-05-24 | Novel acetylsalicylic acid formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE480229T1 true ATE480229T1 (de) | 2010-09-15 |
Family
ID=42676680
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06831741T ATE480229T1 (de) | 2005-05-24 | 2006-05-24 | Orale pharmazeutische zusammensetzung zur behandlung einer cox-2-vermittelten erkrankung |
Country Status (7)
Country | Link |
---|---|
US (1) | US20100009005A1 (de) |
EP (1) | EP1888045B1 (de) |
JP (1) | JP5232641B2 (de) |
AT (1) | ATE480229T1 (de) |
CA (1) | CA2609618C (de) |
DE (1) | DE602006016785D1 (de) |
WO (1) | WO2007036809A2 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5601685B2 (ja) * | 2007-05-09 | 2014-10-08 | ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド | Apo(a)遺伝子における多型はアセチルサリチル酸治療に対する応答性を予測する |
MX362949B (es) * | 2008-12-04 | 2019-02-27 | Yu Chongxi | Composiciones de alta penetracion y sus aplicaciones. |
HUE032426T2 (en) | 2009-05-27 | 2017-09-28 | Alkermes Pharma Ireland Ltd | Inhibition of flake aggregation in nanoparticulate meloxicam formulations |
US20110008432A1 (en) * | 2009-06-25 | 2011-01-13 | Pozen Inc. | Method for Treating a Patient in Need of Aspirin Therapy |
US11696894B2 (en) * | 2013-12-17 | 2023-07-11 | Celsprin Llc | Sequential administration of partitioned absorption aspirin or active aspirin derivative and COX-2 inhibitor |
US20170112858A1 (en) * | 2015-10-27 | 2017-04-27 | New Haven Pharmaceuticals, Inc. | Extended Release Aspirin |
WO2017184489A1 (en) * | 2016-04-18 | 2017-10-26 | Espero Pharmaceuticals Inc. | Higher dose extended release aspirin |
JP2019142860A (ja) * | 2018-02-23 | 2019-08-29 | ライオン株式会社 | 医薬組成物及び医薬製剤 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4507276A (en) * | 1982-08-20 | 1985-03-26 | Bristol-Myers Company | Analgesic capsule |
AU591248B2 (en) * | 1986-03-27 | 1989-11-30 | Kinaform Technology, Inc. | Sustained-release pharaceutical preparation |
AU632602B2 (en) * | 1989-08-02 | 1993-01-07 | John David Arnold | Method and preparation for reducing risk of myocardial infarction |
US5409709A (en) * | 1991-11-29 | 1995-04-25 | Lion Corporation | Antipyretic analgesic preparation containing ibuprofen |
FR2704146B1 (fr) * | 1993-04-19 | 1995-07-13 | Cripdom | Microcapsules d'acide acétylsalicylique à libération contrôlée. |
US5852047A (en) * | 1994-01-28 | 1998-12-22 | Cal International Limited | Pharmaceutical product comprising a salicylate of an esterifiable ace-inhibitor |
FR2725623A1 (fr) * | 1994-10-18 | 1996-04-19 | Flamel Tech Sa | Microcapsules medicamenteuses et/ou nutritionnelles pour administration per os |
US6599529B1 (en) * | 1997-09-11 | 2003-07-29 | Nycomed Danmark A/S | Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (NSAIDs) |
FR2772615B1 (fr) * | 1997-12-23 | 2002-06-14 | Lipha | Comprime multicouche pour la liberation instantanee puis prolongee de substances actives |
US20030180352A1 (en) * | 1999-11-23 | 2003-09-25 | Patel Mahesh V. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
NZ513964A (en) * | 1999-12-08 | 2004-01-30 | Pharmacia Corp | Solid-state form of celecoxib having enhanced bioavailability |
US20020015735A1 (en) * | 1999-12-22 | 2002-02-07 | Hedden David B. | Sustained-release formulation of a cyclooxygenase-2 inhibitor |
US7029701B2 (en) * | 2000-09-11 | 2006-04-18 | Andrx Pharmaceuticals, Llc | Composition for the treatment and prevention of ischemic events |
AU2002257582A1 (en) * | 2001-02-14 | 2002-09-04 | Glaxo Wellcome S.A. | Pharmaceutical formulation |
GB0124459D0 (en) * | 2001-10-11 | 2001-12-05 | Novartis Ag | Organic compounds |
KR20040083478A (ko) * | 2002-01-07 | 2004-10-02 | 파마시아 코포레이션 | 시클로옥시게나제-2 선택성 억제제 및 아스피린의조합물을 이용한 통증, 염증 및 염증-관련 장애의 치료 |
FR2837100B1 (fr) * | 2002-03-18 | 2004-07-23 | Flamel Tech Sa | Comprimes a bases de microcapsules a liberation modifiee |
JP2004188307A (ja) * | 2002-12-11 | 2004-07-08 | Japan Atom Energy Res Inst | リン酸基を有するジルコニウム担持繊維状吸着材の合成方法、及びそれを用いたヒ素の除去 |
US20040121004A1 (en) * | 2002-12-20 | 2004-06-24 | Rajneesh Taneja | Dosage forms containing a PPI, NSAID, and buffer |
-
2006
- 2006-05-24 DE DE602006016785T patent/DE602006016785D1/de active Active
- 2006-05-24 AT AT06831741T patent/ATE480229T1/de not_active IP Right Cessation
- 2006-05-24 EP EP06831741A patent/EP1888045B1/de not_active Not-in-force
- 2006-05-24 US US11/920,749 patent/US20100009005A1/en not_active Abandoned
- 2006-05-24 WO PCT/IB2006/003659 patent/WO2007036809A2/en active Application Filing
- 2006-05-24 CA CA2609618A patent/CA2609618C/en not_active Expired - Fee Related
- 2006-05-24 JP JP2008512954A patent/JP5232641B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2609618C (en) | 2016-01-05 |
WO2007036809A3 (en) | 2007-09-13 |
JP5232641B2 (ja) | 2013-07-10 |
EP1888045A2 (de) | 2008-02-20 |
US20100009005A1 (en) | 2010-01-14 |
EP1888045B1 (de) | 2010-09-08 |
DE602006016785D1 (de) | 2010-10-21 |
WO2007036809A2 (en) | 2007-04-05 |
CA2609618A1 (en) | 2007-04-05 |
JP2008542256A (ja) | 2008-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE480229T1 (de) | Orale pharmazeutische zusammensetzung zur behandlung einer cox-2-vermittelten erkrankung | |
MX338338B (es) | Composiciones y metodos utiles para el tratamiento de enfermedades respiratorias. | |
EA200800064A1 (ru) | Композиция в виде гранул с модифицированным и немедленным высвобождением мемантина | |
DE602005021770D1 (de) | Indol-1-yl-essigsäurederivate | |
DOP2007000053A (es) | Compuestos de tetrahidropiridotienopirimidina y métodos para su empleo | |
EA200701519A1 (ru) | Живая аттенуированная ротавирусная вакцина для перорального введения | |
EA201300242A1 (ru) | Фармацевтические композиции, содержащие замещенные ациланилиды | |
EA200802166A1 (ru) | Стабильная фармацевтическая композиция с защитным действием от раздражения (варианты), способ ее получения и способ лечения кальций-миметиком с ее помощью | |
ECSP17000643A (es) | Combinación farmacéutica que comprende 3-(3-dimetilamino-1etil-2-metil-propil)-fenol y Paracetamol. | |
WO2007125501A3 (en) | Liquid compositions comprising phenylephrine and acetaminophen and their use for the treatment of respiratory illness | |
JP2009531457A5 (de) | ||
EA200801580A1 (ru) | Новые производные пирониндола и способ их получения | |
MX2009008084A (es) | Derivados de 5,6,7,8-tetrahidropteridina como inhibidores de hsp90. | |
EA200901237A1 (ru) | Применение димирацетама при лечении хронической боли | |
NO20076405L (no) | Anvendelse av 24-nor-UDCA | |
BRPI0911678B8 (pt) | maleato de orvepitant cristalino anidro, composição farmacêutica compreedendo o dito maleato e uso do mesmo para o tratamento ou profilaxia de doenças do sistema nervoso central | |
MA32635B1 (fr) | Produit medicamenteux et traitement associe | |
BR112015019776A2 (pt) | comprimidos de duplo uso oral em composições farmacêuticas de sais de sulfato e métodos de uso dos comprimidos | |
WO2007121545A8 (en) | S-nitrosothiols containing compositions for the treatment of fatty liver diseases, obesity and other diseases associated with the metabolic syndrome and the use of such compositions | |
RU2006109966A (ru) | Препарат "янтастим-с" для терапии и профилактики инфекционных заболеваний животных | |
ATE534382T1 (de) | Pharmazeutische zusammensetzungen von mit zuckeralkoholen zusammen mikronisiertem entacapon | |
ES2525376T3 (es) | Composición farmacéutica comprendiendo amlodipino y ácido acetilsalicílico para uso en el tratamiento de hipertensión arterial sistémica | |
AU2016219620A1 (en) | Compositions and methods useful for treatment of respiratory illness | |
DE602006009511D1 (de) | Pharmazeutische Zusammensetzungen zur Behandlung von Hauterkrankungen | |
TH85790B (th) | สารผสมดูแลช่องปากที่ต้านฟันผุด้วยสารทำให้เกิดคีเลต |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |